Abiopharma

Illumina, Inc. - lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Inventiva Annonce la Nomination de Renée Aguiar-Lucander à son Conseil d’Administration

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors

XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense

PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm

Sharps Technology Inc. Notification (STSS)

Life Sciences Investor Forum Agenda Announced for June 11th-12th

Hollow Knight: Silksong Developers Confirm Launch Before Holiday 2025